|
1
|
Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010.
|
Clin J Am Soc Nephrol
|
2012
|
2.39
|
|
2
|
Agalsidase benefits renal histology in young patients with Fabry disease.
|
J Am Soc Nephrol
|
2013
|
2.11
|
|
3
|
Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria.
|
Am J Kidney Dis
|
2008
|
1.53
|
|
4
|
Foot process effacement is an early marker of nephropathy in young classic Fabry patients without albuminuria.
|
Nephron
|
2014
|
1.50
|
|
5
|
Preeclampsia and prevalence of microalbuminuria 10 years later.
|
Clin J Am Soc Nephrol
|
2013
|
1.45
|
|
6
|
[A man in his fifties with fever, cough and anuria].
|
Tidsskr Nor Laegeforen
|
2012
|
1.40
|
|
7
|
Renal artery thrombosis with acute renal failure after withdrawal of angiotensin converting enzyme inhibitor: a case report.
|
Nephrol Dial Transplant
|
2002
|
1.39
|
|
8
|
[A women in her 50s with leg pain and renal failure].
|
Tidsskr Nor Laegeforen
|
2012
|
1.39
|
|
9
|
[A woman with chronic kidney failure, progressive calciphylaxis and sepsis].
|
Tidsskr Nor Laegeforen
|
2008
|
1.38
|
|
10
|
Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.
|
Kidney Int
|
2010
|
1.25
|
|
11
|
Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation.
|
Nephrol Dial Transplant
|
2011
|
1.23
|
|
12
|
Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).
|
Nephrol Dial Transplant
|
2009
|
1.15
|
|
13
|
Mortality in patients with IgA nephropathy.
|
Am J Kidney Dis
|
2013
|
1.03
|
|
14
|
Assessment of kidney volumes from MRI: acquisition and segmentation techniques.
|
AJR Am J Roentgenol
|
2012
|
1.00
|
|
15
|
Long-term risk of cancer in membranous nephropathy patients.
|
Am J Kidney Dis
|
2007
|
1.00
|
|
16
|
Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations.
|
Nephrol Dial Transplant
|
2009
|
0.96
|
|
17
|
Renal complications of Fabry disease in children.
|
Pediatr Nephrol
|
2012
|
0.93
|
|
18
|
Prominence of glomerular and vascular changes in renal biopsies in children and adolescents with Fabry disease and microalbuminuria.
|
Clin Ther
|
2008
|
0.89
|
|
19
|
Preeclampsia in healthy women and endothelial dysfunction 10 years later.
|
Am J Obstet Gynecol
|
2013
|
0.87
|
|
20
|
Fabry or not Fabry--a question of ascertainment.
|
Eur J Hum Genet
|
2011
|
0.86
|
|
21
|
Recommendations on reintroduction of agalsidase Beta for patients with fabry disease in europe, following a period of shortage.
|
JIMD Rep
|
2012
|
0.84
|
|
22
|
Monitoring renal function in children with Fabry disease: comparisons of measured and creatinine-based estimated glomerular filtration rate.
|
Nephrol Dial Transplant
|
2009
|
0.83
|
|
23
|
Uncertain diagnosis of fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-up.
|
JIMD Rep
|
2014
|
0.80
|
|
24
|
Week-to-week biological variation in the N-terminal prohormone of brain natriuretic peptide in hemodialysis patients and healthy individuals.
|
Clin Chem
|
2013
|
0.79
|
|
25
|
C2 monitoring in maintenance renal transplant recipients: is it worthwhile?
|
Transplantation
|
2003
|
0.79
|
|
26
|
Use of 3D DCE-MRI for the estimation of renal perfusion and glomerular filtration rate: an intrasubject comparison of FLASH and KWIC with a comprehensive framework for evaluation.
|
AJR Am J Roentgenol
|
2015
|
0.77
|
|
27
|
CD11c(+) dendritic cells rather than Langerhans cells are reduced in normal skin of immunosuppressed renal transplant recipients.
|
Acta Derm Venereol
|
2014
|
0.76
|
|
28
|
[False measurement of glucose during dialysis with icodextrin].
|
Tidsskr Nor Laegeforen
|
2006
|
0.76
|
|
29
|
Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy.
|
Am J Nephrol
|
2015
|
0.76
|
|
30
|
Laboratory investigation and follow-up of chronic kidney disease stage 3 in primary care.
|
Clin Chim Acta
|
2011
|
0.76
|
|
31
|
[Cognitive failure in terminal kidney disease].
|
Tidsskr Nor Laegeforen
|
2009
|
0.75
|
|
32
|
[Nephrogenic systemic fibrosis and use of MR contrast media].
|
Tidsskr Nor Laegeforen
|
2009
|
0.75
|
|
33
|
Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion.
|
Eur J Clin Invest
|
2010
|
0.75
|
|
34
|
[Staging and measurement of renal function in chronic renal conditions].
|
Tidsskr Nor Laegeforen
|
2006
|
0.75
|